August 24, 2012
Week in Review: JOBS Act Update and Inc. 500|5000
Safeguard Scientifics’ CFO Steve Zarrilli covered the JOBS act as a win for startups, venture capital, and the economy. Since then, the law was passed by Congress…
Posted by
Safeguard Insights
August 24, 2012
Week in Review: Convergence between Life Sciences and Technology and A Look at New Partner Company Medivo
The convergence between life sciences and technology cannot be ignored. That’s why at Safeguard Scientifics, we consolidated of our life sciences and technology deal teams.…
Posted by
NuPathe: FDA CRL Doesn’t Reject NDA or Impact Potential Long-Term Value, Only Delays Launch
The line between long-term value creation and short-term speculative trading was never as stark as it was this week on Tuesday, August 30, after life…
Posted by
Safeguard Scientifics Honored with Investment Deal of the Year at PACT Enterprise Awards
Last night, I had the pleasure of attending the Greater Philadelphia Alliance for Capital and Technologies (PACT) 18th Annual Enterprise Awards. For nearly 60 years,…
Posted by
NuPathe Submits Zelrix NDA for the Treatment of Migraine
Safeguard Scientifics’ partner company NuPathe submitted a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA). The NDA was filed for ZelrixTM,…
Posted by
